A drug developed in Israel to cure COVID-19 was tested in a clinical trial on 30 patients suffering from the disease and reportedly cured 29 of the 30 people.
The trial, conducted at Tel Aviv Sourasky Medical Center, tested an experimental inhaled medication called EXO-CD24. The drug, developed by Ichilov, reportedly stops the “cytokine storm,” the body’s reaction to COVID-19 in which the immune system reacts by savaging healthy cells.
“Cytokine storm and cytokine release syndrome are life-threatening systemic inflammatory syndromes involving elevated levels of circulating cytokines and immune-cell hyperactivation that can be triggered by various therapies, pathogens, cancers, autoimmune conditions, and monogenic disorders. From a historical perspective, cytokine storm was previously referred to as an influenza-like syndrome that occurred after systemic infections such as sepsis and after immunotherapies such as Coley’s toxins,” The New England Journal of Medicine has explained.
“To date, the preparation has been tried with great success on 30 severe patients, in 29 of whom the medical condition